Business Development Partnerships

Translating science into solutions through strategic partnerships

At Celgene, we know that finding the most innovative and effective treatment options for patients may also mean collaborating with others. We constantly evaluate collaboration opportunities that complement our internal research efforts and strategically align with our mission and vision.

We actively seek discovery and development partners in areas such as: developing novel targeted therapies, next generation biologics, protein homeostasis, epigenetics, immunotherapy, stem cell therapy, combination treatments and more.

Below is a list of external collaborators that we work with in our R&D efforts:

  • Abide
  • Acceleron
  • Acetylon Pharmaceuticals, Inc.
  • Adimab
  • Agios
  • AnaptysBio
  • Array BioPharma
  • Baylor
  • BlueBirdBio
  • Blueline Biosciences
  • BMS
  • Clovis
  • Concert
  • Epizyme
  • Forma Therapeutics
  • GlobeImmune
  • IRX
  • MercaChem
  • MorphoSys
  • NantBioscience
  • Nogra
  • OncoMed Pharmaceuticals
  • PharmAkea Therapeutics
  • Presage
  • Sanford Burnham Medical Research Institute
  • Sanofi
  • Sutro BioPharma
  • Tengion
  • Triphase
  • Vaxon Biotech
  • VentiRx Pharmaceuticals

 


UK-CELG150025af
Date of preparation: May 2015